These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22416677)

  • 1. High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience.
    Bojan M; Boulat C; Peperstraete H; Pouard P
    Paediatr Anaesth; 2012 Aug; 22(8):818-25. PubMed ID: 22416677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery.
    Bojan M; Vicca S; Boulat C; Gioanni S; Pouard P
    Br J Anaesth; 2012 May; 108(5):830-7. PubMed ID: 22362670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
    Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
    Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a miniaturized cardiopulmonary bypass circuit in neonates and infants is associated with fewer blood product transfusions.
    Bojan M; Constanza Basto Duarte M; Lopez Lopez V; Tourneur L; Pouard P; Vouhé P
    ASAIO J; 2011; 57(6):527-32. PubMed ID: 22036721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience.
    Fan Y; Lin R; Yang L; Ye L; Yu J; Shu Q
    Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery.
    Schindler E; Photiadis J; Sinzobahamvya N; Döres A; Asfour B; Hraska V
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):495-9. PubMed ID: 20832330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
    Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D
    Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
    Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of aprotinin in neonatal congenital heart operations.
    Wilder NS; Kavarana MN; Voepel-Lewis T; Paugh T; Lee T; Ohye RG
    Ann Thorac Surg; 2011 Sep; 92(3):958-63. PubMed ID: 21871283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin use during cardiac surgery: recent alterations and effects on blood product utilization.
    Strouch ZY; Drum ML; Chaney MA
    J Clin Anesth; 2009 Nov; 21(7):502-7. PubMed ID: 20006258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants.
    Mou SS; Giroir BP; Molitor-Kirsch EA; Leonard SR; Nikaidoh H; Nizzi F; Town DA; Roy LC; Scott W; Stromberg D
    N Engl J Med; 2004 Oct; 351(16):1635-44. PubMed ID: 15483282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.